Literature DB >> 12522455

A fourth case of BCR-FGFR1 positive CML-like disease with t(8;22) translocation showing an extensive deletion on the derivative chromosome 8p.

Massimo Pini, Enrico Gottardi, Patrizia Scaravaglio, Emilia Giugliano, Roberta Libener, Anna Baraldi, Alberto Muzio, Elisa Cornaglia, Giuseppe Saglio, Alessandro Levis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12522455     DOI: 10.1038/sj.thj.6200201

Source DB:  PubMed          Journal:  Hematol J        ISSN: 1466-4860


× No keyword cloud information.
  7 in total

1.  8p11 Myeloproliferative syndrome with t(8;22)(p11;q11): A case report.

Authors:  Jing Jing Liu; Li Meng
Journal:  Exp Ther Med       Date:  2018-06-20       Impact factor: 2.447

2.  A case of acute myelogenous leukaemia characterised by the BCR-FGFR1 translocation.

Authors:  Alexios Matikas; Ifigeneia Tzannou; Dimitra Oikonomopoulou; Maria Bakiri
Journal:  BMJ Case Rep       Date:  2013-03-20

3.  Chronic myelogenous leukemia-like hematological malignancy with t(8;22) in a 26-year-old pregnant woman: A case report.

Authors:  You-Wen Qin; Yi-Ning Yang; Ping Bai; Chun Wang
Journal:  Oncol Lett       Date:  2016-04-27       Impact factor: 2.967

4.  Acute progression of BCR-FGFR1 induced murine B-lympho/myeloproliferative disorder suggests involvement of lineages at the pro-B cell stage.

Authors:  Mingqiang Ren; Josephine A Tidwell; Suash Sharma; John K Cowell
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

5.  Functional characterization of two rare BCR-FGFR1+ leukemias.

Authors:  Evan J Barnes; Jessica Leonard; Bruno C Medeiros; Brian J Druker; Cristina E Tognon
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-04-01

6.  Allogeneic Hematopoietic Stem Cell Transplantation for a BCR-FGFR1 Myeloproliferative Neoplasm Presenting as Acute Lymphoblastic Leukemia.

Authors:  Karl Haslam; Stephen E Langabeer; Johanna Kelly; Natasha Coen; Niamh M O'Connell; Eibhlin Conneally
Journal:  Case Rep Hematol       Date:  2012-10-02

Review 7.  Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1.

Authors:  Ayalew Tefferi
Journal:  J Cell Mol Med       Date:  2008-10-23       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.